Navigation Links
Seroquel to Treat Depression In Case Of Bipolar Disorder

AstraZeneca the Head of the Anglo-Swedish Company has come out with the results of the drug Seroquel stating that it be used in the treatment of // both maniac behaviour and mental depression in people suffering with bipolar disorders.

He has asked US to consider his drug as a sole treatment for maniac and depression symptoms related to bipolar disorder.

AstraZeneca, the drug czar has requested the number of drug regulators spread across the Atlantic to approve Seroquel.

Previously the drug was given permission to be used in the treatment of mania.

But now with his research and other works done at the base in Alderley Edge he has supplied new information based on clinical trail that it is very effective in treating patients suffering from mental depression.

Bipolar disorder is a characteristic mental imbalance in which the individual experience severe mood swings and also feels euphoric during episodes of mania and then immediately suffers from the lows characteristic of mental depression.

The incidence of this disease is very low and is about 3-4 % among the adults. It is the sixth leading cause of disability in the world.

Doctors say that the condition might be associated with genes and may be hereditary. It affects equal number of patients in both the sexes.

The acquiescence of the license for the new drug from the US Food and Drug Administration (FDA) would be an important milestone in the history of the drug.

The drug Seroquel alone spawned a profit of 1.16 billion pounds in 2004.


'"/>




Page: 1

Related medicine news :

1. Astra Zenecas Seroquel Gets FDA Approval For Schizophrenia
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. New FDA Approved Drug To Treat Migraine
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Angiotensin-II-receptor blockers - Treat kidney failure
8. Cipro Has Cheaper Cousins to Treat Anthrax
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. Cyclosporin A Treats Leukemia Complications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this ... The former overall number one pick in the 2001 NFL Draft, to the Atlanta ... record for the most career rushing yards by a quarterback (6,109) and the most ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
Breaking Medicine Technology: